Corante

About this author
Zack Lynch Zack Lynch is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT,Center for Cognitive Liberty & Ethics, the InnerSpace Foundation, the Center for Neuroeconomic Studies and SocialText, a social software company. His book on how brain science is changing our world will be available July 2009. Please send newsworthy items or feedback - to Zack Lynch.
Receive by email

GUEST AUTHOR ARCHIVES
Check out Jevon MacDonald on the "uncertain future of blogging"

Brain Waves

« China - The Brain Science Institute at Fudan University | Main | Institute For The Future to Explore Neurotech Tomorrow »

July 31, 2005

Cogniceuticals Defined in the UK Observer

Email This Entry

Posted by Zack Lynch

John Hind, writer at the UK Observer, recenly picked up on the term "cogniceuticals" in the "What's the Word" column:

Cogniceuticals
n. medicines for saving and increasing cognition

Cogniceuticals are drugs that work on 'knowing' - memory, learning, attention. They are 'the fastest-growing neuro-pharmaceutical market' and are set to be so for several decades, unfolding a 'neurosociety' in which functions of the human mind are protected and then enhanced in earnest. Social and economic forecaster Zack Lynch, author of the daily Brain Waves www.neurosociety.com sees 2010 to 2040 as being a period in which cogniceuticals (and also 'emoticeuticals') will metaphorically move from invention-of-the-wheel stage to intercontinental-flight stage. Lynch sees us taking advantage, via drugs, of the vast amount of data out there. One pundit on businesspundit.com cheers, 'Competitive advantage will come not just from managing knowledge generated within your company, but by cogniceutically managing the ability of your employees to learn, think, be creative ...'

For more on cogniceuticals click here.

Comments (0) + TrackBacks (0) | Category: Cogniceuticals



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
NIO Unveils Top 10 Neuroscience Trends for 2009
NIO CEO Media Tour in NYC Gets Results
O Neurocaster
Manuscript Sent to Japan
2009 Stem Cell Trendsetters in Neurology and Psychiatry
Mental Health Parity Legislation Passes within Financial Package
Holy Neurofinancial Meltdown Bernanke
Interest in Neuropolicy Grows